VALENCIA, Calif., Aug. 8 /PRNewswire-FirstCall/ -- MannKind Corporation will release its 2007 second quarter financial results on Thursday, August 9, 2007 after the close of the financial markets.
Management of the Company will host a conference call to discuss the second quarter financial results and other Company developments at 5:00 p.m. ET on Thursday, August 9, 2007. Presenting from the Company will be its Chairman and Chief Executive Officer, Alfred Mann; President and Chief Operating Officer, Hakan Edstrom; and Corporate Vice President and Chief Financial Officer, Dick Anderson.
To participate in the live call by telephone, please dial (888) 730-9140 or (210) 234-0008. Those interested in listening to the conference call live via the Internet may do so by visiting the Company's website at http://www.mannkindcorp.com.
A telephone replay of the call will be accessible for approximately fourteen days following completion of the call by dialing (800) 756-6235 or (402) 998-0454 and entering conference number 1536761. A replay will also be available on MannKind's website for fourteen days.
About MannKind Corporation
MannKind Corporation focuses on the discovery, development and commercialization of therapeutic products for patients with diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.
MannKind CorporationCONTACT: Dick Anderson, Chief Financial Officer of MannKind Corporation,+1-661-775-5302, danderson@mannkindcorp.com; or Investor Relations, EvanSmith of Financial Dynamics, +1-212-850-5606, mnkd@fd.com, for MannKindCorporation
Web site: http://www.mannkindcorp.com/
